Gregory Gregoriadis
Präsident bei The International Liposome Society
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Colin William Hill | M | 79 |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 Jahre |
| Michael Scott Maguire | M | 61 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 20 Jahre |
| Timothy O’Shea | M | - |
University of London
| 23 Jahre |
| Sanjay Jain | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 23 Jahre |
| Brad Marcus | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 17 Jahre |
| Henry Hoppe | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 12 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Yew Yern Low | M | 45 |
University of London
| 6 Jahre |
| Michal Andrzej Kemp | M | - |
University of London
| 5 Jahre |
| Ron James | M | - |
University of London
| 4 Jahre |
| Wan Fung Yeung | M | 48 |
University of London
| 1 Jahre |
| Shing Ming Hung | M | 47 |
University of London
| 4 Jahre |
| U Ock Ng | M | 53 |
University of London
| 3 Jahre |
| Ronit Satchi-Fainaro | M | 52 |
University of London
| 3 Jahre |
| Wai Fong Yee | F | 58 |
University of London
| 4 Jahre |
| Anna Keay | M | 50 |
University of London
| 5 Jahre |
| Yee Tai Wai | F | 46 |
University of London
| 4 Jahre |
| Kee Sern Lau | M | 48 |
University of London
| 3 Jahre |
| Uza Dheena Hussain | F | - |
University of London
| 1 Jahre |
| Mutsumi Kawashima | F | 53 |
University of London
| 3 Jahre |
| Kin Man Chik | M | 49 |
University of London
| 4 Jahre |
| Jos White | M | - |
University of London
| 3 Jahre |
| Wing Yee Tsang | F | 52 |
University of London
| 1 Jahre |
| Ashraful Hadi | M | - |
University of London
| 3 Jahre |
| Kok Chung Hou | M | 61 |
University of London
| 3 Jahre |
| So Fun Chan | F | 55 |
University of London
| 4 Jahre |
| Mathieu Verly | M | 46 |
University of London
| 3 Jahre |
| Sin Tong Ng | M | 50 |
University of London
| 4 Jahre |
| Suat Lee Gan | F | 47 |
University of London
| 4 Jahre |
| Huey Fei Lee | F | 44 |
University of London
| 1 Jahre |
| Sien Chan Cheang | M | 46 |
University of London
| 4 Jahre |
| Sze Yeen Lee | F | 47 |
University of London
| 4 Jahre |
| Ching Chu Chan | F | 56 |
University of London
| 3 Jahre |
| Yong Ling Yew | F | 53 |
University of London
| 2 Jahre |
| Thee Kit Wang | M | 48 |
University of London
| 4 Jahre |
| Ho Wong | M | 50 |
University of London
| 4 Jahre |
| LISA MARKEY | F | - |
University of London
| 1 Jahre |
| Priyan Manatunga | M | - |
University of London
| 4 Jahre |
| Punit Oza | M | - |
University of London
| 1 Jahre |
| Peyman Faratin | M | - |
University of London
| 5 Jahre |
| Hamad Abdullah Al-Attiyah | M | - |
University of London
| 1 Jahre |
| John Farrugia | M | 47 |
University of London
| 4 Jahre |
| Ivan Yeo | M | - |
University of London
| 4 Jahre |
| Sandrine Massiani | F | 53 |
University of London
| 2 Jahre |
| Soon Lai Yeoh | M | 44 |
University of London
| 3 Jahre |
| Siu Ling Chaio | F | 51 |
University of London
| 4 Jahre |
| Keng Tat Goh | M | 49 |
University of London
| 3 Jahre |
| Yuen Hang Chan | M | 50 |
University of London
| 3 Jahre |
| Will Liam Leong | M | 44 |
University of London
| 4 Jahre |
| Fei Chan | M | 49 |
University of London
| 3 Jahre |
| Tak Shing Choi | M | 48 |
University of London
| 4 Jahre |
| M. Umapathy Sivan | M | 50 |
University of London
| 2 Jahre |
| Yuen Har Lim | F | - |
University of London
| 4 Jahre |
| Li Ngut Lee | F | 49 |
University of London
| 4 Jahre |
| Ya Zhao | M | 54 |
University of London
| 3 Jahre |
| Chi Wai Wan | M | 48 |
University of London
| 3 Jahre |
| Ajay K. Agrawal | M | - |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | - |
| Cheng Tuck Kuan | M | 52 |
University of London
| 3 Jahre |
| Pang Yen Ong | M | 62 |
University of London
| 3 Jahre |
| Mohammad Ghaith Ali Mohammad Mismar | M | 62 |
University of London
| 3 Jahre |
| Henry J. Freeman | M | - |
University of London
| 4 Jahre |
| Weng Hung Mun | M | 48 |
University of London
| 4 Jahre |
| Michael Minor | M | - |
University of London
| 2 Jahre |
| Akshay Vaishnaw | M | 61 |
University of London
| 3 Jahre |
| Chun Fung Ma | M | 54 |
University of London
| 3 Jahre |
| Firdaus Jal Dastoor | M | 72 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 7 Jahre |
| Sau Fan Leung | F | 61 |
University of London
| 3 Jahre |
| Ajit Kadirgamar | M | - |
University of London
| 3 Jahre |
| Mani Honigstein | M | - |
University of London
| 3 Jahre |
| Billy Cheung | M | 61 |
University of London
| 3 Jahre |
| Wiktor Pawel Sliwinski | M | 44 |
University of London
| 4 Jahre |
| Wai Ming Yip | M | 59 |
University of London
| 3 Jahre |
| Kuang Yu Cao | M | 69 |
University of London
| 1 Jahre |
| Roo Rogers | M | - |
University of London
| 1 Jahre |
| Peter Brumm | M | 49 |
University of London
| 1 Jahre |
| Victor G. Bulmer-Thomas | M | 76 |
University of London
| 6 Jahre |
| Sau Fong Leung | F | - |
University of London
| 4 Jahre |
| Yuk Ming Leung | M | 50 |
University of London
| 3 Jahre |
| G. Russell Croft | M | 51 |
University of London
| 2 Jahre |
| Jana Sivcova | F | 54 |
University of London
| 3 Jahre |
| Michael Jarasitis | M | - |
University of London
| 1 Jahre |
| Feroze Varun Gandhi | M | 44 |
University of London
| 4 Jahre |
| Najla Al Jamali | F | - |
University of London
| 1 Jahre |
| Yan Wing Chan | M | 44 |
University of London
| 4 Jahre |
| Shagufa R. Hossain | F | - |
University of London
| 3 Jahre |
| Buhdy Bok | M | 52 |
University of London
| 3 Jahre |
| Kathrin Buvac | F | 44 |
University of London
| 4 Jahre |
| Kin Wai Tse | M | 46 |
University of London
| 3 Jahre |
| Geraldine Venthoye | M | - |
University of London
| 13 Jahre |
| Sharmila Gunam | F | - |
University of London
| 4 Jahre |
| John Felix | M | - |
University of London
| 3 Jahre |
| Roman Sergeevich Knyazev | M | 44 |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | 1 Jahre |
| Po Chuen Kwan | M | 65 |
University of London
| 1 Jahre |
| Haw So | M | 41 |
University of London
| 4 Jahre |
| Hisham Hasan | M | - |
University of London
| 3 Jahre |
| Damir Kaufman | M | 49 |
University of London
| 3 Jahre |
| Hessa bint Khalifa Al-Khalifa | F | - |
University of London
| 11 Jahre |
| Sook Kuan Loh | F | - |
University of London
| 3 Jahre |
| Othman Abdullah bin Othman Al-Suwaih | M | 63 |
University of London
| 3 Jahre |
| Chi Hong Lau | M | 53 |
University of London
| 1 Jahre |
| Feng Yue | M | 42 |
University of London
| 4 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigtes Königreich | 100 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Gregory Gregoriadis
- Persönliches Netzwerk